Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Modular metabolic engineering of lysine supply for enhanced production of bacitracin in Bacillus licheniformis.

Wu F, Cai D, Li L, Li Y, Yang H, Li J, Ma X, Chen S.

Appl Microbiol Biotechnol. 2019 Nov;103(21-22):8799-8812. doi: 10.1007/s00253-019-10110-y. Epub 2019 Sep 14.

PMID:
31522285
2.

The RIG-I pathway is involved in peripheral T cell lymphopenia in patients with dermatomyositis.

Zhang L, Xia Q, Li W, Peng Q, Yang H, Lu X, Wang G.

Arthritis Res Ther. 2019 May 29;21(1):131. doi: 10.1186/s13075-019-1905-z.

3.

Specific Autoantibodies and Clinical Phenotypes Correlate with the Aberrant Expression of Immune-Related MicroRNAs in Dermatomyositis.

Ye L, Zuo Y, Yang H, Li W, Peng Q, Lu X, Wang G, Shu X.

J Immunol Res. 2019 Feb 19;2019:2927061. doi: 10.1155/2019/2927061. eCollection 2019.

4.

The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies.

Li S, Ge Y, Yang H, Wang T, Zheng X, Peng Q, Lu X, Wang G.

Clin Rheumatol. 2019 Aug;38(8):2171-2179. doi: 10.1007/s10067-019-04503-7. Epub 2019 Mar 12.

PMID:
30863950
5.

The Regulatory T Cell in Active Systemic Lupus Erythematosus Patients: A Systemic Review and Meta-Analysis.

Li W, Deng C, Yang H, Wang G.

Front Immunol. 2019 Feb 18;10:159. doi: 10.3389/fimmu.2019.00159. eCollection 2019.

6.

A high-density genetic map of Schima superba based on its chromosomal characteristics.

Zhang R, Yang H, Zhou Z, Shen B, Xiao J, Wang B.

BMC Plant Biol. 2019 Jan 25;19(1):41. doi: 10.1186/s12870-019-1655-8.

7.

Correction to: identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study.

Yang H, Peng Q, Yin L, Li S, Shi J, Zhang Y, Lu X, Shu X, Zhang S, Wang G.

Arthritis Res Ther. 2018 Apr 11;20(1):71. doi: 10.1186/s13075-018-1549-4.

8.

Differential Clinical Associations of Anti-Nuclear Matrix Protein 2 Autoantibodies in Patients With Idiopathic Inflammatory Myopathies.

Yang H, Lu X, Peng Q, Jiang W, Shi J, Zhang Y, Chen H, Wang G.

Arthritis Rheumatol. 2018 Aug;70(8):1288-1297. doi: 10.1002/art.40491. Epub 2018 Jun 27.

9.

Increased Levels of Soluble Programmed Death Ligand 1 Associate with Malignancy in Patients with Dermatomyositis.

Chen H, Peng Q, Yang H, Yin L, Shi J, Zhang Y, Wang G.

J Rheumatol. 2018 Jun;45(6):835-840. doi: 10.3899/jrheum.170544. Epub 2018 Feb 1.

PMID:
29419471
10.

Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study.

Yang H, Peng Q, Yin L, Li S, Shi J, Zhang Y, Lu X, Shu X, Zhang S, Wang G.

Arthritis Res Ther. 2017 Nov 25;19(1):259. doi: 10.1186/s13075-017-1469-8. Erratum in: Arthritis Res Ther. 2018 Apr 11;20(1):71.

11.

Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies.

Shi J, Li S, Yang H, Zhang Y, Peng Q, Lu X, Wang G.

J Rheumatol. 2017 Jul;44(7):1051-1057. doi: 10.3899/jrheum.161480. Epub 2017 May 1.

PMID:
28461650
12.

The clinical utility of serum IL-35 in patients with polymyositis and dermatomyositis.

Yin L, Ge Y, Yang H, Peng Q, Lu X, Zhang Y, Wang G.

Clin Rheumatol. 2016 Nov;35(11):2715-2721. Epub 2016 Aug 8.

PMID:
27502600
13.

Significant decrease in peripheral regulatory B cells is an immunopathogenic feature of dermatomyositis.

Li W, Tian X, Lu X, Peng Q, Shu X, Yang H, Li Y, Wang Y, Zhang X, Liu Q, Wang G.

Sci Rep. 2016 Jun 7;6:27479. doi: 10.1038/srep27479.

15.

Factors predicting malignancy in patients with polymyositis and dermatomyostis: a systematic review and meta-analysis.

Lu X, Yang H, Shu X, Chen F, Zhang Y, Zhang S, Peng Q, Tian X, Wang G.

PLoS One. 2014 Apr 8;9(4):e94128. doi: 10.1371/journal.pone.0094128. eCollection 2014. Review.

Supplemental Content

Loading ...
Support Center